1. Home
  2. SYRE
  3. SYRE News

Latest Spyre Therapeutics Inc. (SYRE) News on July 8, 2024

Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-α4β7 Antibody, for the Treatment of Inflammatory Bowel Disease

PR Newswire

20 days ago

Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-α4β7 Antibody, for the Treatment of Inflammatory Bowel Disease

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Adapthealth Corp Earnings Call

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Kforce Inc Earnings Call

Share on Social Networks: